Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study

Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study

Abstract Objective Local combined systemic therapy has been an important method for the treatment of unresectable hepatocellular carcinoma (HCC).The purpose of this study was to compare the effectiveness and safety of transarterial chemoembolization (TACE) plus Sorafenib versus TACE plus Apatinib fo...

Full description

Bibliographic Details
Main Authors: Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Yu-Lin Tan, Guo-Xiang Wang, Jia-Ying Dai, Xian-Hai Zhu, Bo Jiang
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Cancer Imaging
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Sorafenib
Apatinib
Clinical outcomes
Online Access:https://doi.org/10.1186/s40644-023-00574-7

Internet

https://doi.org/10.1186/s40644-023-00574-7

Similar Items